Novo Nordisk A/S Class B · BCBA:NVO.CI

Novo Nordisk A/S Class B financial statements

Novo Nordisk A/S Class B's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in DKK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue309.1B290.4B232.3B177.0B140.8B126.9B122.0B111.8B111.7B111.8B
Cost of revenue58.8B44.5B35.8B28.4B23.7B20.9B20.1B17.6B17.6B17.2B
Gross profit250.3B245.9B196.5B148.5B117.1B106.0B101.9B94.2B94.1B94.6B
Research and development52.0B48.1B32.4B24.0B17.8B15.5B14.2B14.8B14.0B14.6B
Selling, general and administrative5.97B5.28B61.6B4.47B4.05B3.96B4.01B3.92B3.78B3.96B
Operating income127.7B128.3B102.6B74.8B58.6B54.1B52.5B47.2B49.0B48.4B
Depreciation and amortization14.7B8.54B9.41B7.36B6.03B5.75B5.66B3.92B3.18B3.19B
EBITDA142.3B136.9B112.0B82.2B64.7B59.9B58.1B51.2B52.1B51.6B
Interest expense6.78B7.35B845.0M378.0M2.45B390.0M220.0M85.0M90.0M65.0M
Income before tax130.5B127.2B104.7B69.1B59.1B53.1B48.6B47.6B48.7B47.8B
Income tax28.1B26.2B21.0B13.5B11.3B11.0B9.60B8.99B10.6B9.87B
Net income102.4B101.0B83.7B55.5B47.8B42.1B39.0B38.6B38.1B37.9B
Earnings per share, basic23.0622.6718.6712.2210.379.008.197.977.697.48
Earnings per share, diluted23.0322.6318.62

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents26.5B15.7B14.4B12.7B10.7B12.8B15.5B15.6B18.9B18.7B
Short-term investments498.0M10.7B15.8B10.9B6.76B02.30B2.01B
Receivables70.9B71.9B64.8B57.5B46.8B32.2B29.2B26.9B23.6B24.2B
Inventory49.6B40.8B31.8B24.4B19.6B18.5B17.6B16.3B15.4B14.3B
Current assets172.5B161.8B139.6B108.2B85.6B65.8B62.5B59.1B60.1B59.8B
Property, plant and equipment208.4B161.7B66.7B55.4B50.3B50.6B41.9B35.2B30.2B
Goodwill19.8B20.0B4.46B5.09B4.35B0
Total assets542.9B465.6B314.5B241.3B194.5B144.9B125.6B110.8B102.4B97.5B
Accounts payable19.8B17.1B25.6B15.6B8.87B5.72B6.36B6.76B5.61B6.01B
Current liabilities215.7B217.6B169.7B120.9B99.5B70.3B59.0B54.2B47.1B47.4B
Long-term debt118.9B89.7B16.0B20.8B9.65B
Total debt131.0B102.8B27.0B25.8B26.6B10.4B4.48B515.0M1.69B229.0M
Total liabilities348.9B322.1B207.9B157.8B123.8B81.6B68.0B58.9B52.5B52.3B
Shareholders' equity194.0B143.5B106.6B83.5B70.7B63.3B57.6B51.8B49.8B45.3B
Shares outstanding4.45B4.46B4.46B4.54B4.61B4.68B4.76B4.85B4.96B5.07B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations119.1B121.0B108.9B78.9B55.0B52.0B46.8B44.6B41.2B48.3B
Capital spending-60.1B-47.2B-25.8B-14.8B-7.38B-22.1B-11.2B-12.4B-8.65B-8.27B
Free cash flow59.0B73.8B83.1B64.1B47.6B29.9B35.6B32.2B32.5B40.0B
Cash from investing-79.2B-128.9B-43.9B-24.9B-31.6B-22.4B-11.5B-12.1B-6.57B-6.79B
Cash from financing-28.4B8.73B-63.2B-51.8B-25.5B-32.2B-35.5B-34.5B-35.7B-38.9B
Dividends paid-51.8B-44.1B-31.8B-25.3B-21.5B-20.1B-19.4B-19.0B-18.8B-23.8B
Share buybacks-1.39B-20.2B-29.9B-24.1B-19.4B-16.9B-15.3B-15.6B-16.8B-15.1B
Change in cash11.5B808.0M1.86B1.93B-1.51B-3.19B-218.0M-1.53B-1.30B2.61B